US2014248326A1PendingUtilityA1

Encapsulated kidney tissue

56
Assignee: ATRM LLCPriority: Dec 20, 2007Filed: May 16, 2014Published: Sep 4, 2014
Est. expiryDec 20, 2027(~1.4 yrs left)· nominal 20-yr term from priority
A61P 9/00A61P 5/00A61P 7/06A61P 3/00A61P 13/12A61L 27/365A61K 9/0024A61L 27/34A61L 27/3604A61K 35/22A61K 9/1652A61L 27/3683A61K 9/48A61K 35/12A61L 27/3804
56
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Provided are therapeutic implants comprising renal tissue encapsulated within a polymer bead. Also disclosed are methods for treating a disease state in a subject comprising implanting within said subject a therapeutic implant comprising renal tissue encapsulated within a polymer bead. Also provided are methods for making a therapeutic implant comprising: providing renal tissue; mixing the renal tissue with a solution comprising a polymer, thereby forming a tissue-polymer suspension; extruding the tissue-polymer suspension into an bead-forming solution, thereby forming a therapeutic implant comprising beads of said polymer within which the renal tissue is encapsulated.

Claims

exact text as granted — not AI-modified
What is claimed: 
     
         1 . A method for treating a disease state in a subject comprising implanting within said subject a therapeutic implant comprising whole fragments of renal tissue encapsulated within a polymer bead. 
     
     
         2 . The method according to  claim 1 , wherein said disease state is anemia, stroke, cardiovascular disease, or renal disease. 
     
     
         3 . The method according to  claim 1 , wherein said renal tissue is autologous tissue, allogeneic tissue, xenogeneic tissue, or any combination thereof. 
     
     
         4 . The method according to  claim 1 , wherein said renal tissue comprises genetically-altered cells. 
     
     
         5 . The method according to  claim 1 , wherein fragments of whole renal tissue have a size of less than about 1 mm. 
     
     
         6 . The method according to  claim 1 , wherein fragments of whole renal tissue have a size of less than about 300 μm. 
     
     
         7 . The method according to  claim 1 , wherein said therapeutic implant comprises at least about 30 mg of renal tissue. 
     
     
         8 . The method according to  claim 1 , wherein said polymer bead comprises alginate, hyaluronic acid, carboxymethylcellulose, polyethylene glycol, dextran, agarose, poly-L-lysine, carageenan, pectin, tragacanth gum, xanthan gum, guar gum, gum arabic, type I collagen, laminin, fibronectin, fibrin, or any combination thereof. 
     
     
         9 . The method according to  claim 1 , wherein said polymer bead comprises alginate and poly-L-lysine. 
     
     
         10 . The method according to  claim 1 , wherein said polymer bead has a diameter of about 3 mm to about 6 mm. 
     
     
         11 . The method according to  claim 1 , wherein said tissue secretes one or more hormones, prohormones, proteins, growth factors, or any combination thereof. 
     
     
         12 . The method according to  claim 11 , wherein said tissue secretes one or more of erythropoietin, MCP-1, adiponectin, leptin, and MMP-2. 
     
     
         13 . The method of  claim 1 , wherein said fragments of whole renal tissue are excised and minced. 
     
     
         14 . The method of  claim 1 , wherein said fragments are encapsulated with a growth medium. 
     
     
         15 . The method of  claim 1 , wherein said polymer bead is permeable to substances secreted by said fragments of whole renal tissue.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.